194 related articles for article (PubMed ID: 19103524)
1. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.
Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW
Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524
[TBL] [Abstract][Full Text] [Related]
2. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
[TBL] [Abstract][Full Text] [Related]
3. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
4. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
[TBL] [Abstract][Full Text] [Related]
5. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.
Plantinga TS; Crisan TO; Oosting M; van de Veerdonk FL; de Jong DJ; Philpott DJ; van der Meer JW; Girardin SE; Joosten LA; Netea MG
Gut; 2011 Sep; 60(9):1229-35. PubMed ID: 21406388
[TBL] [Abstract][Full Text] [Related]
7. Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease.
van Heel DA; Hunt KA; King K; Ghosh S; Gabe SM; Mathew CG; Forbes A; Playford RJ
Inflamm Bowel Dis; 2006 Jul; 12(7):598-605. PubMed ID: 16804397
[TBL] [Abstract][Full Text] [Related]
8. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
9. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
10. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
11. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
[TBL] [Abstract][Full Text] [Related]
12. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
13. Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.
Zelinkova Z; van Beelen AJ; de Kort F; Moerland PD; Ver Loren van Themaat E; te Velde AA; van Deventer SJ; de Jong EC; Hommes DW
Inflamm Bowel Dis; 2008 Feb; 14(2):186-94. PubMed ID: 17941075
[TBL] [Abstract][Full Text] [Related]
14. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
Mann JK; Shen J; Park S
J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
[TBL] [Abstract][Full Text] [Related]
16. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
17. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells.
Vissers M; Remijn T; Oosting M; de Jong DJ; Diavatopoulos DA; Hermans PW; Ferwerda G
Eur J Immunol; 2012 Oct; 42(10):2727-35. PubMed ID: 22730064
[TBL] [Abstract][Full Text] [Related]
19. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
[TBL] [Abstract][Full Text] [Related]
20. Detection of muramyl dipeptide-sensing pathway defects in monocytes of patients with Crohn's disease using phospho-specific whole blood flow cytometry.
Kuuliala K; Lappalainen M; Turunen U; Puolakkainen P; Kemppainen E; Siitonen S; Repo H; Mustonen H
Scand J Clin Lab Invest; 2013 Sep; 73(6):494-502. PubMed ID: 23837874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
